European AIDS Treatment Group Published 2025 Annual Report
The report highlights major achievements in testing, policy advocacy, and the conclusion of a five-year strategy.
Updated on Sept. 29, 2026 in LGBTQand
Live Poll
Do you trust that non-profit advocacy groups effectively influence public health policies and standards?
The European AIDS Treatment Group released its 2025 annual report, marking the conclusion of its 2020-2025 long-term strategy. The organization is now transitioning toward the development of a new strategic framework for future initiatives.
Why it matters
The report documents significant advancements in HIV prevention and clinical research advocacy across Europe. It serves as a foundation for EATG as it shifts focus to address evolving healthcare needs for people living with HIV.
EATG supported 84,700 testing opportunities across 10 EU countries and reached 38,000 monthly website visitors in 2025. Membership grew to 148 individuals representing 37 countries.
The players
European AIDS Treatment Group
An NGO that advocates for the rights and interests of people living with or affected by HIV in the European region.
The details
The organization implemented the CORE project, which notably contributed to the approval of free PrEP in Cyprus. Additionally, EATG launched the READI initiative to promote inclusive clinical research and published guidance on HIV inclusion in non-HIV clinical trials.
Timeline
The EATG long-term strategy was executed from 2020 to 2025.
The annual report covers the organization's activities throughout 2025.
The 2025 annual report was officially published on September 29, 2026.
Culture Shift
The EATG policy analysis provides a seven-country evaluation of the Glasgow Manifesto on ageing with HIV. The report extends the impact of the manifesto by producing a multi-country policy analysis to improve care for an ageing HIV-positive population.
The organization's advocacy efforts, such as the push for free PrEP, directly increase access to preventative healthcare for individuals in the European Union. These initiatives simplify the process for patients seeking testing and clinical inclusion across member states.
The takeaway
The conclusion of the 2020-2025 strategy marks a pivotal transition period for HIV advocacy in Europe. Stakeholders should monitor upcoming announcements as the organization establishes its new strategic goals for the coming years.
Further reading
Learn more about advocacy and health equity by visiting the LGBTQand section.
Source note: This article includes information reported by EATG.
Live Poll
Do you trust that non-profit advocacy groups effectively influence public health policies and standards?
